Dr. Steven Narod, MD, FRCPC
Dr. Steven Narod is a Tier I Canada Research Chair in Breast Cancer, a University of Toronto professor in the Dalla Lana School of Public Health and the Department of Medicine, and a senior scientist at Women’s College Research Institute, where he leads the Familial Breast Cancer Research Unit.
Dr. Steven Narod has a long-standing commitment to breast cancer research. He leads many collaborative research projects in breast cancer in the areas of prevention, screening, inherited breast cancer, public health applications of genetic technology and predictors of breast cancer mortality, in Canada and around the world.
Click here for more information about Dr. Steven Narod.
Dr. May Lynn Quan, MD, MSc, FRCSC
Dr. May Lynn Quan is a breast surgical oncologist and health services researcher focusing on quality and delivery of cancer care. She is an associate professor in the Department of Surgery and Oncology, University of Calgary, and is the interim medical director and surgical lead of the Calgary Breast Health Program.
Dr. May Lynn Quan has expertise in large cohort and database studies using cancer registries and administrative dataset linkages at the Institute for Clinical Evaluative Sciences (ICES) in Ontario and the Alberta Cancer Registry in Alberta. Having practiced in Ontario at Sunnybrook and now currently in Calgary, Dr. Quan has been a key member in both provincial tumour group executives and guideline development groups.
Click here for more information about Dr. May Lynn Quan.
Dr. Nancy Baxter, MD, PhD, FRCSC, FACRS
(Sub-Project Principal Investigator) – Knowledge to Action: Improving local therapy for young women with breast cancer across Canada
Dr. Nancy Baxter is the chief of the Division of General Surgery at St. Michael’s Hospital and a scientist in the Li Ka Shing Knowledge Institute. She holds the position of associate professor in the Department of Surgery at the University of Toronto and is a senior scientist in the Cancer Theme Group, Institute for Clinical Evaluative Sciences.
Dr. Nancy Baxter has extensive experience in health services research in survivorship, measurement, systematic reviews and knowledge translation. She holds the Cancer Care Ontario Health Services Research Chair.
Click here for more information about Dr. Nancy Baxter.
Dr. Christine Friedenreich, PhD
(Sub-Project Principal Investigator) – The impact of modifiable lifestyle factors in breast cancer survival in young women
Dr. Christine Friedenreich is the scientific leader of the Department of Cancer Epidemiology and Prevention Research at Alberta Health Services, and the Alberta Cancer Foundation Weekend to End Women’s Cancers Breast Cancer Chair at the University of Calgary.
She is a cancer epidemiologist with extensive experience in the design and conduct of large cohort studies and randomized controlled trials in physical activity and cancer control that include the lifestyle assessment and biomarkers.
Click here for more information about Dr. Christine Friedenreich.
Dr. Kelly Metcalfe, RN, PhD
(Sub-Project Principal Investigator) – Expanded Genetic Testing in Women with Young Onset Breast Cancer
. Kelly Metcalfe is a professor at the Lawrence S. Blomberg Faculty of Nursing, University of Toronto and an adjuct scientist at Women’s College Research Institute.
She has expertise in the areas of delivery of cancer genetics services and treatment of BRCA-associated breast cancer. She has previously led studies examining the uptake of genetic testing in newly diagnosed ovarian cancer patients, satisfaction with genetic testing, and the treatment of hereditary breast cancer.
Click here for more information about Dr. Kelly Metcalfe.
Dr. Ellen Warner, MD, FRCPC, FACP, MSc
(Sub-Project Principal Investigator) – SPOKE & GYPSY: Studies to Encourage Early Fertility Preservation Referral and to Predict Effects of Treatment on Fertility of Young women with Breast Cancer
Dr. Ellen Warner is a medical oncologist at the Sunnybrook Regional Cancer Center and is the founder and director of PYNK, the only program in Canada for young women with breast cancer. She is an affiliate scientist at the Evaluative Clinical Sciences platform, Odette Cancer Research Program, and a professor at the Department of Medicine, University of Toronto.
Dr. Ellen Warner has extensive experience leading inter-disciplinary research teams, most notably a study of MRI screening for BRCA mutation carriers. She is a member of the Ontario Regional Advisory Program for adolescents and young adults and its oncofertility subcommittee. She also is a member of Fertile Future’s medical advisory board.
Click here for more information about Dr. Ellen Warner.
Other RUBY study researchers are:
- Dr. Mohammad Akbari (Co-Investigator), Women’s College Hospital
- Dr. Ivo Olivotto (Co-Investigator), Alberta Health Services
- Dr. Geoff Porter (Co-Investigator), Beatrice Hunter Cancer Research Institute
- Dr. Martin Chang (Collaborator), Mount Sinai Hospital
- Dr. Tak Wah Mak (Collaborator), Ontario Cancer Institute
- Dr. Sambasivarao Damaraju (Collaborator), University of Alberta
To see the complete list of collaborating RUBY surgeons, click here.